On the stock market since 2006, it operates in the world of health and science. It has 725 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades 58% below its peak. The market has trimmed its expectations for the company.
There is $159.8M in the vault; even if every debt were paid off, $139.5M would remain.
A loss of $36.9M against $236.2M in annual sales. And on top of that, sales fell from the year before.
The stock trades 13% above the average analyst price target.
On our five-subject report card, CSII sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CSII is a small company that closed last year at a loss. The road back to profit runs through spending discipline.